¡¾²Î¿¼ÎÄÏס¿
  1 Kanski JJ. Clinical Ophthalmology: a systematic approach 5th Ed. Butterworthª²Heinemann China 2003;334ª²340

2 Imhof SM, Moll AC, Schoutenª²van Meeteren AY. Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands. Br J Ophthalmol 2006;90(7):875ª²878

3 Lueder GT. The effect of initial recognition of abnormalities by physicians on outcome of retinoblastoma. J AAPOS 2005;9(4):383ª²385

4 Adejor GO. Retinoblastoma as seen at National Eye Centre, Kadunaª²a four year retrospective study from June 1993ª²June 1997. Nig J Ophthalmol 1998;6:9ª²15

5 Onwasigwe EN. Essentials of general ophthalmology. Institute of Development

Studies Enugu 2004;224ª²239

6 Messmer EP, Heinrich T, H¢‰pping W, de Sutter E, Havers W, Sauerwein W. Risk factors for metastases in patients with retinoblastoª²ma. Ophthalmology 1991;98(2):136ª²141

7 G¨¹nd¨¹z K, M¨¹ft¨¹oglu O, G nalp I, Unal E, Ta¢“yildiz N. Metastatic retinoblastoma clinical feature, treatment and prognosis. Ophthalmology 2006;113(9):1558ª²1566

8 Chang CY, Chiou TJ, Hwang B, Bai LY, Hsu WM, Hsieh YL. Retinoblastoma in Taiwan, survival rate and prognostic factors. Jpn J

Ophthalmol 2006;50(3):242ª²249

9 Lealª²Leal CA, Riveraª²Luna R, Floresª²Rojo M, Ju¢~rezª²Echenique JC, Ordaz JC, Amadorª²Zarco J. Survival in extraª²orbital metastatic retinoblastoma: treatment results. Clin Transl Oncol 2006;8(1):39ª² 44

10 Hungerford J. Retinoblastoma. Community Eye Health1990;5:2ª²6

ÉÏÒ»Ò³  [1] [2] [3]